A mutant of Escherichia coli with a partially defective phosphoribosylpyrophosphate synthetase (ribosephosphate pyrophosphokinase) has been characterized genetically. The genetic lesion causing the altered phosphoribosylpyrophosphate synthetase, prs, was mapped at 26 min on the linkage map by conjugation. Transductional analysis of the prs region established the gene order as purB-fadRdadR-tre-pth-prs-hemA-trp. Two additional mutations were identified in the mutant: one in gsk, the gene encoding guanosine kinase, and one in Ion, conferring a mucoid colony morphology. The contribution of each mutation to the phenotype of the mutant has been evaluated.
Phosphoribosylpyrophosphate (PRPP) synthetase (ribosephosphate pyrophosphokinase; ATP:D-ribose-5-phosphate pyrophosphotransferase, EC 2.7.6.1) catalyzes the formation of PRPP from ATP and ribose-5-phosphate. PRPP is an important intermediate in cellular metabolism, being a component in the biosynthesis of purine and pyrimidine nucleotides, of the coenzymes NAD+ and NADP+, and of the amino acids histidine and tryptophan. In nucleotide and coenzyme synthesis, PRPP is consumed by both the de novo pathways and by auxiliary pathways, i.e., enzymatic reactions utilizing exogenously added or endogenously formed adenine, hypoxanthine, xanthine, guanine, uracil, and nicotinic acid for nucleotide synthesis. Thus, a total of 10 enzymes compete for PRPP as a substrate in Escherichia coli and Salmonella typhimurium. The PRPP synthetase reaction therefore constitutes the branch point of a highly branched pathway and is subjected to metabolic regulation (24, 32) . Among the many compounds formed from PRPP, ADP has been shown to be the most potent inhibitor of PRPP synthetase from S. typhimurium (6, 30) . In addition, it has been shown that a pyrimidine nucleotide is involved in the repression of the synthesis of the enzyme (22) . Otherwise, the genetics of the synthesis of PRPP synthetase and its regulation have not been elucidated. The isolation of a mutant of E. coli with defective PRPP synthetase has been reported from this laboratory (12). The mutant was isolated from a purine-requiring strain defective in purnne nucleoside phosphorylase and adenine phosphoribosyltransferase (i.e., genotype purE deoD apt). This strain cannot utilize nucleosides as purine sources. Mutants able to grow with guanosine as the sole purine source were selected. The (17) , CGSC N. Kleckner R. Simons (27) R. Simons (27) a Gene symbols are from Bachmann and Low (1) . b Also harbors rpsL relA supF metB. C This mutation results in a functional gene product with altered enzymatic properties. d Also harbors purE deoD apt. ' Mutations in lacY were selected as described (28) . f The deoD strains were constructed as follows. Low-thymine-requiring derivatives (thy deoB) were prepared (3, 29) . Then, deoB was exchanged with deoD with P1(S0446), and thy was removed by transduction. (20) . Recombinants from conjugations, recombinants from transductions, and sexductants were always reisolated at least once before use. Hem' transductants were selected on succinate minimal plates lacking -aminolevulinic acid, and hemA was scored on L-broth plates; fadR was scored on plates with decanoic acid as the carbon source (27) ; dadR was scored on plates with n-tryptophan serving as tryptophan source (9) (Table 2) . However, the fact that Ion strains form mucoid colonies allows discrimination between prs Ion' and prs+ Ion.
Screening assay of PRPP synthetase. To make possible the screening of recombinants for the PRPP synthetase phenotype (i.e., increased Km for ribose-5-phosphate and ATP) independently of other phenotypes, a simple screening assay was developed. This assay was based on the kinetic properties of the mutant enzyme. Thus, the ATP concentration was far below the Km value for ATP of the mutant enzyme. The activity of the wild-type enzyme, when determined by the screening assay, was 50% of the activity obtained when assayed under optimal conditions, whereas the residual activity of the mutant enzyme was only 1% of the activity obtained under optimal conditions. Figure 1 shows the result obtained by submitting 11 and 2',3'-dideoxyadenosine phenotypic traits are all displayed by the prs mutation (a 100% coincidence of the three phenotypes was found).
Transductional mapping of prs. The mapping data presented above suggest that the prs locus is located in the 25-to 27-min region of the linkage map. Therefore, attempts were made to map further the prs locus in the purB-trp region. Results of two four-factor crosses are shown in Table 3 . The data indicate the gene order purBfadR-prs-hemA-trp. Cotransduction of purB with prs was 4.5%, and cotransduction of purB with hemA was 2.8%. However, among the 10 purB+ hemA+ transductants, 9 inherited the prs mutant allele from the donor, showing linkage of prs with hemA, which would not be expected if the gene order were prs-purB-hemA. The cotransduction frequency of purB with fadR was 58%, giving the gene order above. Analogous rationalization with hemA+ selection gives the same gene order. The cotransduction of hemA with prs was 82%. When trp+ was the selected marker, prs was located as described above between fadR and hemA (Table 3) .
To map further the prs locus relative to other genetic markers in the fadR-hemA region, the two crosses shown in Table 4 were carried out. By using a rationale similar to that above, it can be concluded that in the hemA+ selection all the unselected markers are on the fadR side of hemA. In the TnJO selection all the unselected markers, except dadR, are on the hemA side of fadR. There was a slight discrepancy with re- none of these markers mapped within the purBtrp region since none showed linkage with zcg-2402::TnlO (jOint transduction frequencies less than 0.5%).
As mentioned previously, the mutant had a twofold increase in PRPP synthetase activity. This property was found to be linked to the Km defect: all prs+ recombinants assayed under optimal conditions showed normal activity (40 U/mg of protein), and all prs recombinants had increased activity (90 U/mg of protein).
Analysis ofprs merodiploid strains. The kinetic properties of the mutant PRPP synthetase presented here and elsewhere (12) indicate that the prs locus is the gene encoding PRPP synthetase. To further assess this aspect, the F125 episome, covering the purB-trp region, was transferred into prs+ recA and prs recA strains (HO286 and H0287, respectively). A gene dosage effect was observed in the prs+/Fprs+ strain since the total PRPP synthetase activity was 68 U/mg of protein in the merodiploid as compared with 40 U/ mg of protein in the prs+ haploid strain. This indicates that the gene encoding PRPP synthetase resides on the F125 episome. In the prsl Fprs+ strain, the PRPP synthetase activity showed kinetic properties different from those observed for both prs and prs+ strains; the Km value for ATP of the enzyme from the merodiploid strain was lower than that from the prs strain but higher than that from the prs+ strain.
Given the knowledge that PRPP synthetase is multimeric (26), the results presented above suggest that prs is the structural gene for PRPP synthetase.
Other properties of strain S01172. The data presented in Fig. 2 suggest that the guanosine growth property and the Km defect of PRPP synthetase were caused by two independent mutations. The guanosine growth locus mapped at 12 min, indicating that the gsk gene, encoding guanosine kinase, might be affected. This was confirmed by further genetic analysis (data not shown). In accordance with these data, the guanosine kinase of strain S01172 has been shown to have altered thermal and kinetic properties in vitro (P. Nygaard, personal communication).
The growth properties of strains harboring either gsk or prs were analyzed. The data indicate that growth on guanosine is mainly caused by the gsk mutation and that growth is somewhat improved by introduction ofprs in addition to gsk. Apparently there may be a selective advantage of the gsk prs double mutant over the gsk single mutant (data not shown).
Yet a third genetic lesion in strain S01172 was identified within the Ion gene (Fig. 2) . Analysis of a lon' derivative (HO72) of the mutant as well as a lon derivative (HO74) of the parent revealed no effect of lon on PRPP or purine nucleotide metabolism as examined by analysis of PRPP VOL. 154, 1983 on October 28, 2017 by guest http://jb.asm.org/ inhibited by nucleoside analogs such as 2',3'-dideoxyadenosine, 2',5'-dideoxyadenosine (31), or 5'-deoxyadenosine (11) .
The prs locus was mapped by a series of fourand six-factor crosses. Since in many crosses the Prs phenotype was scored by assay of PRPP synthetase, such crosses were preferred over two-and three-factor crosses, thereby reducing the number of recombinants that had to be assayed. Transductional analysis revealed a location of the prs gene very close to hemA, and the detailed map of the prs region (Fig. 3) included several markers not previously located accurately. Since mutants with deficiencies in PRPP synthetase have been isolated in S. typhimurium (see below), it is of interest to note that the prs gene is flanked by genes known to be located on a chromosomal fragment with inverted gene orders between E. coli and S. typhimurium (1, 21, 25) . These genes are dadR, tre, and hemA (2, 33, 34) . Therefore, prs must also be on this fragment, and if a homologous locus is present in S. typhimurium, it should be located near hemA.
A PRPP synthetase mutant of S. typhimurium has been isolated by the same approach used for the E. coli prs mutant described here (14). The mutation was located at 7 map units on the S. typhimurium linkage map. However, more recent experiments have located the lesion approximately 2 map units clockwise of pyrF (B. Hove-Jensen, unpublished results), which is at 33 map units. This map position therefore seems to be analogous to the prs locus in E. coli and is in agreement with the prediction made above, i.e., the gene encoding PRPP synthetase in S. typhimurium is located on the inverted chromosomal segment near hemA.
Interpretation of the results is slightly complicated by the results obtained with another mutant of S. typhimurium. It was isolated by screening temperature-sensitive mutants for lack of PRPP synthetase activity in vitro (23) . This mutation was mapped at 47 map units. The molecular defect of the latter mutant remains to be established. It is probably not the structural gene, as PRPP synthetase consists of only a single species of subunit (26) . Alternatively, it may be a regulatory gene, or the gene product may be involved in post-translational modification of PRPP synthetase, although at present there is no evidence for such a modification of PRPP synthetase.
